Profile
Linda N.
Liu worked as a Senior Director at MaxCyte, Inc. from 2000 to 2007.
She then worked as an Executive Director at Amplimmune, Inc. from 2007 to 2015.
Prior to that, she worked as a Senior Scientist at Osiris Therapeutics, Inc. from 1999 to 2000.
Currently, she is working as a Senior Vice President at NextCure, Inc. since 2015.
Dr. Liu completed her undergraduate degree from Wuhan University and her doctorate from The University of Texas at Austin.
Former positions of Linda Liu
| Companies | Position | End |
|---|---|---|
| NEXTCURE, INC. | Chief Tech/Sci/R&D Officer | 2022-01-31 |
Amplimmune, Inc.
Amplimmune, Inc. BiotechnologyHealth Technology Develops immune-based biological treatments | Corporate Officer/Principal | 2015-07-31 |
| MAXCYTE, INC. | Corporate Officer/Principal | 2006-12-31 |
| OSIRIS THERAPEUTICS, INC. | Corporate Officer/Principal | 1999-12-31 |
Training of Linda Liu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Osiris Therapeutics, Inc.
Osiris Therapeutics, Inc. BiotechnologyHealth Technology Researches and develops therapeutic products for the regeneration of human connective tissues | Health Technology |
MaxCyte, Inc.
MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Amplimmune, Inc.
Amplimmune, Inc. BiotechnologyHealth Technology Develops immune-based biological treatments | Health Technology |
Wuhan University
Wuhan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextCure, Inc.
NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
- Stock Market
- Insiders
- Linda Liu
















